CMRX news

Latest 1 stories · newest Nov 14, 2026

CMRX
CorMedix Announces Q3 2026 Earnings

CorMedix reported Q3 2026 earnings; the company announced a proposed acquisition of Heron Therapeutics assets. Market relevance: indicates a period of corporate transition and M&A activity.

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same CMRX feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/CMRX/newsSTART FREE